GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Masimo Corp (LTS:0JZ2) » Definitions » Cyclically Adjusted Revenue per Share

Masimo (LTS:0JZ2) Cyclically Adjusted Revenue per Share : $24.45 (As of Jun. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Masimo Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Masimo's adjusted revenue per share for the three months ended in Jun. 2024 was $9.140. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $24.45 for the trailing ten years ended in Jun. 2024.

During the past 12 months, Masimo's average Cyclically Adjusted Revenue Growth Rate was 14.70% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 18.70% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 16.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Masimo was 18.70% per year. The lowest was 2.70% per year. And the median was 11.30% per year.

As of today (2024-09-24), Masimo's current stock price is $123.615. Masimo's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2024 was $24.45. Masimo's Cyclically Adjusted PS Ratio of today is 5.06.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Masimo was 20.97. The lowest was 2.33. And the median was 8.85.


Masimo Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Masimo's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Masimo Cyclically Adjusted Revenue per Share Chart

Masimo Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.22 13.54 16.00 19.11 22.74

Masimo Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.21 22.66 22.74 23.56 24.45

Competitive Comparison of Masimo's Cyclically Adjusted Revenue per Share

For the Medical Devices subindustry, Masimo's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Masimo's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Masimo's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Masimo's Cyclically Adjusted PS Ratio falls into.



Masimo Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Masimo's adjusted Revenue per Share data for the three months ended in Jun. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=9.14/132.5538*132.5538
=9.140

Current CPI (Jun. 2024) = 132.5538.

Masimo Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201409 2.639 100.428 3.483
201412 3.044 99.070 4.073
201503 2.864 99.621 3.811
201506 2.901 100.684 3.819
201509 2.842 100.392 3.752
201512 3.157 99.792 4.193
201603 3.295 100.470 4.347
201606 3.276 101.688 4.270
201609 3.129 101.861 4.072
201612 3.713 101.863 4.832
201703 3.541 102.862 4.563
201706 3.423 103.349 4.390
201709 3.443 104.136 4.383
201712 3.740 104.011 4.766
201803 3.837 105.290 4.831
201806 3.796 106.317 4.733
201809 3.745 106.507 4.661
201812 3.947 105.998 4.936
201903 4.354 107.251 5.381
201906 4.024 108.070 4.936
201909 3.999 108.329 4.893
201912 4.324 108.420 5.286
202003 4.682 108.902 5.699
202006 5.171 108.767 6.302
202009 4.772 109.815 5.760
202012 5.095 109.897 6.145
202103 5.165 111.754 6.126
202106 5.315 114.631 6.146
202109 5.328 115.734 6.102
202112 5.678 117.630 6.398
202203 5.309 121.301 5.802
202206 10.222 125.017 10.838
202209 10.153 125.227 10.747
202212 11.426 125.222 12.095
202303 10.386 127.348 10.811
202306 8.369 128.729 8.618
202309 8.885 129.860 9.069
202312 10.203 129.419 10.450
202403 9.092 131.776 9.146
202406 9.140 132.554 9.140

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Masimo  (LTS:0JZ2) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Masimo's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=123.615/24.45
=5.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Masimo was 20.97. The lowest was 2.33. And the median was 8.85.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Masimo Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Masimo's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Masimo Business Description

Industry
Traded in Other Exchanges
Address
52 Discovery, Irvine, CA, USA, 92618
Masimo Corp is a global technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.

Masimo Headlines

No Headlines